These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6204535)

  • 1. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
    Grill V; Efendić S
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
    Grill V; Efendić S
    Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
    Grill V; Rundfeldt M
    Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by IBMX, fasting and experimental diabetes of glibenclamide-induced islet hormone release from the perfused rat pancreas.
    Ostenson CG; Grill V; Nylén A; Efendić S
    Diabete Metab; 1983 Mar; 9(1):58-65. PubMed ID: 6189748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the abnormal pancreatic D and A cell function in streptozotocin diabetic dogs: studies with D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-glucose, and L-arginine.
    Hermansen K
    Diabetologia; 1981 Nov; 21(5):489-94. PubMed ID: 6117495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrient-induced priming of insulin and glucagon secretion. Effects of alpha-ketoisocaproic acid.
    Grill V
    Endocrinology; 1982 Mar; 110(3):1013-7. PubMed ID: 6173206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic A- and D-cell response to arginine during acute alloxan-induced intra-islet insulinopenia.
    Gregorio F; Cristallini S; Carloni C; Gubbiotti G; Pippi R; Filipponi P
    Diabetes Res Clin Pract; 1988 Jan; 4(2):89-94. PubMed ID: 2893695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of D- and A-cell insensitivity to glucose in alloxan-diabetic dogs by treatment with the artificial beta cell (Biostator).
    Hermansen K; Schmitz O; Orskov H
    Diabetes; 1985 Mar; 34(3):260-6. PubMed ID: 2857668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
    Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
    J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of pancreatic somatostatin secretion corrected by in vivo insulin treatment of streptozotocin-diabetic rats.
    Trimble ER; Gerber PP; Renold AE
    Diabetes; 1981 Oct; 30(10):865-7. PubMed ID: 6168508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuel-induced insulin release in vitro from insulinomas transplanted into the rat kidney.
    Hoenig M; Ferguson DC; Matschinsky FM
    Diabetes; 1984 Jan; 33(1):1-7. PubMed ID: 6140199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia.
    Grill V; Westberg M; Ostenson CG
    J Clin Invest; 1987 Sep; 80(3):664-9. PubMed ID: 2442195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose stimulation of beta-cell DNA replication in the intact rat and in pancreatic islets in suspension culture. Effects of alpha-ketoisocaproic acid, dibutyryl cyclic AMP, and 3-isobutyl-1-methylxanthine in the in vitro system.
    Logothetopoulos J; Valiquette N; Cvet D
    Diabetes; 1983 Dec; 32(12):1172-6. PubMed ID: 6197329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in dose-response curves for glucose-induced insulin and somatostatin release in rat pancreas.
    Dettori-Gera C; Ronner P; Scarpa A
    Biochim Biophys Acta; 1985 May; 839(3):281-6. PubMed ID: 2580562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a thiazide diuretic (hydroflumethiazide) and a loop diuretic (bumetanide) on the endocrine pancreas: studies in vitro.
    Hermansen K; Schmitz O; Mogensen CE
    Metabolism; 1985 Aug; 34(8):784-9. PubMed ID: 2862565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas.
    Giroix MH; Portha B; Kergoat M; Bailbe D; Picon L
    Diabetes; 1983 May; 32(5):445-51. PubMed ID: 6341128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral trypsin-inhibitor-induced improvement of the exocrine and endocrine pancreatic functions in alloxan diabetic rats.
    Ihse I; Lundquist I; Arnesjö B
    Scand J Gastroenterol; 1976; 11(4):363-8. PubMed ID: 779003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for calcium in the insulin hypersecretory state of the endotoxic rat pancreas.
    Yelich MR; Filkins JP
    Circ Shock; 1984; 14(1):49-62. PubMed ID: 6207953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.